Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Forst

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Diabetes Technology & Therapeutics|February 14, 2006
Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetesT Forst, A Caduff, M Talary, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 1995
Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitusT Forst, A Pfützner, P Kann, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 14, 2003
Pilot study with technosphere/PTH(1-34)--a new approach for effective pulmonary delivery of parathyroid hormone (1-34)A Pfützner, F Flacke, R Pohl, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 15, 2003
Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetesT Forst, J W Eriksson, H-J Strotmann, et al.
Clinical Laboratory|July 5, 2005
Clinical and laboratory evaluation of a new specific ELISA for intact proinsulinA Pfützner, A H Pfützner, P H Kann, et al.
Circulation|May 11, 2005
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized studyM R Langenfeld, T Forst, C Hohberg, et al.
Clinical Laboratory|December 21, 2006
A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groupsA Weise, U Lambertz, N Thomé, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2010
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetesT Forst, B Uhlig-Laske, A Ring, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 26, 1998
The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion moleculesT Kunt, T Forst, O Harzer, et al.
Clinical Science (London, England : 1979)|December 19, 1998
Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end productsT Kunt, T Forst, A Wilhelm, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Diabetes Technology & Therapeutics|February 14, 2006
Impact of environmental temperature on skin thickness and microvascular blood flow in subjects with and without diabetesT Forst, A Caduff, M Talary, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 1, 1995
Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitusT Forst, A Pfützner, P Kann, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 14, 2003
Pilot study with technosphere/PTH(1-34)--a new approach for effective pulmonary delivery of parathyroid hormone (1-34)A Pfützner, F Flacke, R Pohl, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|May 15, 2003
Metabolic effects of mealtime insulin lispro in comparison to glibenclamide in early type 2 diabetesT Forst, J W Eriksson, H-J Strotmann, et al.
Clinical Laboratory|July 5, 2005
Clinical and laboratory evaluation of a new specific ELISA for intact proinsulinA Pfützner, A H Pfützner, P H Kann, et al.
Circulation|May 11, 2005
Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized studyM R Langenfeld, T Forst, C Hohberg, et al.
Clinical Laboratory|December 21, 2006
A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groupsA Weise, U Lambertz, N Thomé, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 10, 2010
Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetesT Forst, B Uhlig-Laske, A Ring, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 26, 1998
The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion moleculesT Kunt, T Forst, O Harzer, et al.
Clinical Science (London, England : 1979)|December 19, 1998
Alpha-lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end productsT Kunt, T Forst, A Wilhelm, et al.
Pageof 10